Medication info
Rozetelpin Tablet 40/10/10/5 Milligrams

Rozetelpin Tablet 40/10/10/5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tablet
Manufacturer / importer
Green Cross Corporation
Appearance
Pink oval film-coated tablet
Packaging
30 Tablets/Box [6 Tablets/PTP X 5]
Approval status
Active

MFDS item code 202202189 · Approved 2022.05.23 · Insurance code 643606450

Summary

Main use
Treatment of dyslipidemia (including hypercholesterolemia) and essential hypertension
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older adults: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 20/10mg daily. Patients taking the telmisartan/amlodipine combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Green Cross Corporation

Efficacy & effects

Treatment of dyslipidemia (including hypercholesterolemia) and essential hypertension

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used for patients who need to take both the combination of Telmisartan and Amlodipine, as well as the combination of Rosuvastatin and Ezetimibe. It is mainly prescribed for patients whose blood pressure and cholesterol levels need to be controlled at the same time, specifically for hypertension and dyslipidemia. The combination of Telmisartan and Amlodipine is effective for patients with essential hypertension who struggle to control their blood pressure with monotherapy. Additionally, the combination of Rosuvastatin and Ezetimibe helps to manage cholesterol and triglyceride levels in patients with primary hypercholesterolemia or familial and non-familial mixed dyslipidemia. This medication works to reduce total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol while increasing HDL cholesterol when used alongside dietary measures. Therefore, it is used to effectively improve hypertension and dyslipidemia.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older adults: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 20/10mg daily. Patients taking the telmisartan/amlodipine combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication may pose a serious risk to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. If symptoms such as muscle pain or weakness appear, you must notify a healthcare professional immediately, and in some cases, discontinuation of the medication may be required. Patients with poor liver or kidney function must consult with healthcare professionals before taking this medication, and regular liver and kidney function tests are necessary. This medication should not be taken with certain liver diseases, muscle disorders, severe renal impairment, and it is necessary to inform the doctor before taking if there are any other medications. Low blood volume or sodium levels may cause hypotension for effective hypertension treatment, therefore caution is required, and should hypotensive symptoms appear, you must notify a healthcare professional immediately. This medication may increase blood potassium levels, so caution is needed with potassium supplements or potassium-containing drugs. In some patients, side effects such as angioedema, allergic reactions, liver dysfunction, gastrointestinal disturbances, and renal function decline may occur, and if these symptoms occur, you must notify a healthcare professional immediately. While taking this medication, avoid driving or operating machinery as dizziness or drowsiness may occur. Certain genetic factors, elderly patients, those with hypothyroidism, and diabetics may be at a higher risk for side effects, so it’s recommended to consult with a doctor before taking and to regularly monitor conditions during treatment. There may be interactions with other medications, so if currently taking any other medications, it’s essential to inform your healthcare provider, especially with diuretics, anticoagulants, some antibiotics, and grapefruit juice. This medication should be used alongside dietary measures, and regular blood tests and physical examinations should be conducted to check for adverse reactions during treatment.

Side effects

Eyelid damage, head injury, urinary difficulty, flushing, chronic gastritis, various gastrointestinal disorders, hiatal hernia, facial edema, unusual sensations, drug intolerance, irritable bowel syndrome, colon polyps, esophagitis, dizziness, somnolence, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue inflammation, hepatic steatosis, liver dysfunction, hepatic toxicity, acute hepatitis, toxic hepatitis, gamma-glutamyl transferase increase, increased blood cholesterol, increased blood alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, cold sweat, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory difficulties, pelvic pain, breast cysts, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, upper respiratory tract infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, indigestion, abdominal bloating, vomiting, abdominal discomfort, dry mouth, abnormal liver function, liver damage, increased sweating, itching, rash, erythema, vascular edema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, increased blood creatinine, increased blood uric acid, elevated liver enzymes, increased serum creatine kinase, reduced hemoglobin, headache, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, weakness, edema, decreased libido, facial swelling, alopecia, conjunctivitis, sounds in the ear, petechiae, headache, dizziness, constipation, nausea, pancreatitis, pruritus, myopathy, rhabdomyolysis, weakness, arthralgia, sensory abnormalities, chest discomfort, loss of appetite, abdominal bloating, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, thrombocytopenia, increased blood creatinine, acute renal failure, oliguria, increased blood creatinine, thrombocytopenia, headache, dizziness, cough, palpitations, vasculitis, hypertonia, sensory loss, sensory abnormalities, peripheral neuropathy, syncope, taste abnormalities, tremors, epigastric pain, vomiting, abdominal pain, gastritis, constipation, dry mouth, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, sputum, runny nose, limb pain, arthralgia, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, pruritus, upper respiratory tract infection, conjunctival hyperemia, renal failure, abnormal liver function, increased blood creatinine, increased blood pressure, increased blood urea, elevated CPK, abnormal liver function tests, anaphylaxis, urticaria, rash, vascular edema, hypersensitivity reaction, erythema multiforme, arthralgia, myalgia, increased creatine phosphokinase, myopathy, rhabdomyolysis, elevated liver aminotransferases, hepatitis, abdominal pain, thrombocytopenia, nausea, pancreatitis, dizziness, sensory abnormalities, depression, headache, cholelithiasis, cholecystitis, fatigue, chest pain, chest discomfort, edema, weakness, generalized edema, headache, diabetic neuropathy, tremors, epigastric pain, vomiting, abdominal pain, gastritis, constipation, dry mouth, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, sputum, runny nose, limb pain, arthralgia, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, pruritus, upper respiratory tract infection, conjunctival hyperemia, renal failure, abnormal liver function, increased blood creatinine, increased blood pressure, increased blood urea, elevated CPK, abnormal liver function tests, anaphylaxis, urticaria, rash, vascular edema, hypersensitivity reaction, erythema multiforme, arthralgia, myalgia, increased creatine phosphokinase, myopathy, rhabdomyolysis, elevated liver aminotransferases, hepatitis, abdominal pain, thrombocytopenia, nausea, pancreatitis, dizziness, sensory abnormalities, depression, headache, cholelithiasis, cholecystitis, severe skin adverse reactions, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, immune-mediated necrotizing myopathy, severe myasthenia gravis, ocular myasthenia gravis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. It is best to maintain a storage temperature between 1°C to 30°C to ensure the effectiveness and safety of the medication.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 Tablets/Box [6 Tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.